Get research updatesAttention-deficit/hyperactivity disorder (ADHD) involves persistent difficulties with attention, impulsivity or restlessness that can affect everyday life.
NWP06 in the Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD)- A Laboratory Classroom Study
This study has finished and is no longer accepting participants.
Multiple locations, including IrvineResearchers compared Methylphenidate Hydrochloride and Lisdexamfetamine Dimesylate to find out how the approaches affected ADHD symptoms in children with ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including CalgaryResearchers are comparing Adhansia XR and Concerta to find out how the approaches affect ADHD symptoms in young people with ADHD.
This study ended early.
Multiple locations, including Dothan
Role of Transcranial Direct Current Stimulation (tDCS) in Patients With Attention Deficit Hyperactivity Disorder (ADHD)
This study has finished and is no longer accepting participants.
In Porto AlegreThis study evaluated the safety and effectiveness of Mexidol for people with ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including YekaterinburgThis study evaluated the safety and effectiveness of Methylphenidate Transdermal System for people with ADHD.
This study has finished and is no longer accepting participants.
Location not clearly listedA Phase 3, Randomized, Double-blind, Multicenter, Parallel-group, Placebo-controlled, Fixed-Dose Safety and Efficacy Study of SPD489 Compared With Placebo in Preschool Children Aged 4-5 Years With Attention-deficit/Hyperactivity Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including DothanA Phase 3, Randomized, Double-blind, Multicenter, Placebo-controlled, Forced-dose Titration, Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD)
This study has finished and is no longer accepting participants.
Multiple locations, including EncinoResearchers compared SHP465 and placebo to find out how the approaches affected ADHD symptoms in children and adolescents with ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including DothanResearchers are studying SHP465, tracking side effects to assess safety and tolerability in children with ADHD.
This study ended early.
Multiple locations, including DothanThis study evaluated the safety of SHP465 for people with ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockA Phase 4, Open-label, Safety, Tolerability And Pharmacokinetic Study Of Methylphenidate Hydrochloride (Hcl) Extended Release Chewable Tablet (Erct) In 4-5 Year Old Children With Attention Deficit Hyperactivity Disorder (Adhd)
This study was withdrawn before enrollment.
Location not clearly listedWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.